ํƒ€์šฐ๋ฆฐ์ด๋ž€?

ํƒ€์šฐ๋ฆฐ(Taurine)์€ ์‚ฌ๋žŒ์—๊ฒŒ ์ค‘์š”ํ•œ ์•„๋ฏธ๋…ธ์‚ฐ์ž…๋‹ˆ๋‹ค.1 ์‹ ์ฒด์—์„œ ๊ฐ€์žฅ ๋งŽ์ด ํ™œ์šฉ๋˜๋Š” ๋ฌผ์งˆ์ธ ์•„๋ฏธ๋…ธ์‚ฐ์€ ์‚ฌ์Šฌ๋กœ ์—ฐ๊ฒฐ๋˜์–ด ๋‹จ๋ฐฑ์งˆ์„ ํ˜•์„ฑํ•ฉ๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ํƒ€์šฐ๋ฆฐ์€ ๋‹จ๋ฐฑ์งˆ์„ ๋งŒ๋“œ๋Š” ๋ฐ ์‚ฌ์šฉ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ๊ทธ ๋Œ€์‹  ํƒ€์šฐ๋ฆฐ์€ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ํŠน๋ณ„ํ•œ ๊ธฐ๋Šฅ์„ ์ˆ˜ํ–‰ํ•ฉ๋‹ˆ๋‹ค.

  • ๋ฐฐ๋ณ€์„ ํ†ตํ•ด ์ฝœ๋ ˆ์Šคํ…Œ๋กค, ํ˜ธ๋ฅด๋ชฌ, ๋…์†Œ๋ฅผ ์ œ๊ฑฐํ•˜๊ณ  ์ง€๋ฐฉ(์ง€์งˆ)์„ ํก์ˆ˜ํ•˜๋Š” ๋ฐ ๋„์›€์ด ๋˜๋Š” ๋‹ด์ฆ™์—ผ์„ ํ˜•์„ฑํ•ฉ๋‹ˆ๋‹ค.
  • ์ˆ˜๋ถ„ ๊ณต๊ธ‰๊ณผ ์ „ํ•ด์งˆ ๊ท ํ˜•์„ ๋•๊ณ  ์„ธํฌ๋ง‰์„ ์•ˆ์ •ํ™”ํ•จ์œผ๋กœ์จ ์„ธํฌ์˜ ์ „ํ•˜๋ฅผ ์ ์ • ์ˆ˜์ค€์œผ๋กœ ์œ ์ง€ํ•ฉ๋‹ˆ๋‹ค.
  • ์‹ ๊ฒฝ๊ณผ ๊ทผ์œก์ด ์ •์ƒ์ ์œผ๋กœ ๊ธฐ๋Šฅํ•˜๋Š” ๋ฐ ์ค‘์š”ํ•ฉ๋‹ˆ๋‹ค.
  • ์„ธํฌ ๋‚ด ๊ธฐ๋Šฅ์„ ์กฐ์ ˆํ•˜๋Š” ๋ฐ ์ค‘์‹ฌ์ ์ธ ์—ญํ• ์„ ํ•ฉ๋‹ˆ๋‹ค.
  • ์ฒด๋‚ด์—์„œ ์ฃผ์š”ํ•œ ํ•ญ์‚ฐํ™”์ œ ๋ฐ ํ•ญ์—ผ์ œ๋กœ ๊ธฐ๋Šฅํ•ฉ๋‹ˆ๋‹ค.
  • ๋ฉด์—ญ๊ณ„ ๊ฑด๊ฐ• ๋ฐ ๋ฉด์—ญ ๊ธฐ๋Šฅ์„ ์ง€์›ํ•ฉ๋‹ˆ๋‹ค.

ํƒ€์šฐ๋ฆฐ์„ ํ•จ์œ ํ•œ ์‹ํ’ˆ

ํƒ€์šฐ๋ฆฐ(Taurine)์ด๋ผ๋Š” ๋ง์€ ํ™ฉ์†Œ๋ฅผ ์˜๋ฏธํ•˜๋Š” ๋ผํ‹ด์–ด 'ํƒ€์šฐ๋ฃจ์Šค(Taurus)'์—์„œ ์œ ๋ž˜ํ–ˆ๋Š”๋ฐ, ์ด๋Ÿฐ ์ด๋ฆ„์ด ๋ถ™์—ฌ์ง„ ์ด์œ ๋Š” ํƒ€์šฐ๋ฆฐ์ด 1827๋…„ ํ™ฉ์†Œ ๋‹ด์ฆ™์—์„œ ์ฒ˜์Œ ๋ถ„๋ฆฌ๋˜์—ˆ๊ธฐ ๋•Œ๋ฌธ์ž…๋‹ˆ๋‹ค. ๋˜ํ•œ ํƒ€์šฐ๋ฆฐ์ด ํ™ฉ์†Œ ๊ณ ํ™˜์— ๋น„๊ต์  ๋†’์€ ๋†๋„๋กœ ๋ถ„ํฌํ•˜๊ธฐ ๋•Œ๋ฌธ์ด๊ธฐ๋„ ํ•ฉ๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ํƒ€์šฐ๋ฆฐ์˜ ์ฃผ์š” ๊ณต๊ธ‰์›์€ ์ƒ์„ ์„ ๋น„๋กฏํ•œ ๋‹ค์–‘ํ•œ ํ•ด์‚ฐ๋ฌผ, ์œก๋ฅ˜, ์œ ์ œํ’ˆ์ž…๋‹ˆ๋‹ค. 

์‹๋ฌผ์„ฑ ์‹ํ’ˆ์€ ๋Œ€์ฒด์ ์œผ๋กœ ํƒ€์šฐ๋ฆฐ ํ•จ๋Ÿ‰์ด ๋‚ฎ์Šต๋‹ˆ๋‹ค. ์ด ๋•Œ๋ฌธ์— ๋น„๊ฑด ์‹๋‹จ์„ ๋”ฐ๋ฅด๋Š” ์‚ฌ๋žŒ์€ ํƒ€์šฐ๋ฆฐ ์ˆ˜์น˜๊ฐ€ ๋‚ฎ์€ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค. ์ •๊ธฐ์ ์œผ๋กœ ํƒ€์šฐ๋ฆฐ์ด ํ’๋ถ€ํ•œ ์‹ํ’ˆ์„ ์„ญ์ทจํ•˜๋Š” ์‚ฌ๋žŒ๋“ค์˜ ํ•˜๋ฃจ ํƒ€์šฐ๋ฆฐ ์„ญ์ทจ๋Ÿ‰์€ ๋ณดํ†ต 125-175mg์ž…๋‹ˆ๋‹ค. ๋น„๊ฑด ์‹์‚ฌ์—๋Š” ํƒ€์šฐ๋ฆฐ์ด ๊ฑฐ์˜ ๋“ค์–ด ์žˆ์ง€ ์•Š์ง€๋งŒ, ์œ ์ œํ’ˆ๊ณผ ๊ณ„๋ž€์ด ํ—ˆ์šฉ๋˜๋Š” ๋ฝํ†  ์˜ค๋ณด(Lacto-ovo) ์‹๋‹จ์—๋Š” ํ•˜๋ฃจ ์•ฝ 15mg์˜ ํƒ€์šฐ๋ฆฐ์ด ํฌํ•จ๋ฉ๋‹ˆ๋‹ค.1

๋˜ํ•œ ํƒ€์šฐ๋ฆฐ์€ ์ฒด๋‚ด์—์„œ ํ•ฉ์„ฑ๋˜๊ธฐ๋„ ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ํƒ€์šฐ๋ฆฐ์˜ ๋Œ€๋ถ€๋ถ„์€ ๊ฐ„์—์„œ ์•„๋ฏธ๋…ธ์‚ฐ์ธ ์‹œ์Šคํ…Œ์ธ(Cysteine)์œผ๋กœ๋ถ€ํ„ฐ ํ•ฉ์„ฑ๋ฉ๋‹ˆ๋‹ค. ๊ฑด๊ฐ•ํ•œ ์„ฑ์ธ์˜ ์‹ ์ฒด์—์„œ๋Š” ํ•˜๋ฃจ 50-125mg์˜ ํƒ€์šฐ๋ฆฐ์ด ์ƒ์„ฑ๋ฉ๋‹ˆ๋‹ค. ํƒ€์šฐ๋ฆฐ์„ ๋งŽ์ด ์„ญ์ทจํ• ์ˆ˜๋ก ์ฒด๋‚ด ์ƒ์„ฑ๋Ÿ‰์€ ๊ฐ์†Œํ•˜๋Š” ๊ฒƒ์œผ๋กœ ์ถ”์ •๋ฉ๋‹ˆ๋‹ค. ๊ฐ„ ๊ธฐ๋Šฅ ์ €ํ•˜, ๋น„๋งŒ, ๋‹น๋‡จ๋ณ‘, ๊ฐ์—ผ ๋“ฑ๊ณผ ๊ฐ™์€ ๊ฑด๊ฐ• ๋ฌธ์ œ๋ฅผ ๊ฒช๊ณ  ์žˆ๊ฑฐ๋‚˜ ์ŠคํŠธ๋ ˆ์Šค๋ฅผ ๋ฐ›๋Š” ์‚ฌ๋žŒ์˜ ๊ฒฝ์šฐ์—๋„ ๊ฐ„์—์„œ ํƒ€์šฐ๋ฆฐ์ด ๋œ ์ƒ์„ฑ๋ฉ๋‹ˆ๋‹ค. ๋˜ํ•œ ์œ ์•„๋ฅผ ๋น„๋กฏํ•œ ์–ด๋ฆฐ์ด(ํŠนํžˆ ๋ฏธ์ˆ™์•„)๋Š” ํƒ€์šฐ๋ฆฐ์„ ์ถฉ๋ถ„ํžˆ ์ƒ์‚ฐํ•˜์ง€ ๋ชปํ•˜๊ธฐ ๋•Œ๋ฌธ์— ํƒ€์šฐ๋ฆฐ ์ˆ˜์น˜๊ฐ€ ๋‚ฎ์€ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค.1  

์‹ ์ฒด์— ๋งค์šฐ ์ค‘์š”ํ•œ ์•„๋ฏธ๋…ธ์‚ฐ์ด์ง€๋งŒ ๋งŽ์€ ๊ฒฝ์šฐ ์‹ ์ฒด์—์„œ ํ•„์š”ํ•œ ๋งŒํผ ์ถฉ๋ถ„ํžˆ ์ƒ์„ฑ๋˜์ง€ ์•Š๋Š”๋‹ค๋Š” ์‚ฌ์‹ค ๋•Œ๋ฌธ์— ํƒ€์šฐ๋ฆฐ์€ ์กฐ๊ฑด๋ถ€ ํ•„์ˆ˜ ์•„๋ฏธ๋…ธ์‚ฐ์œผ๋กœ ๋ถ„๋ฅ˜๋ฉ๋‹ˆ๋‹ค. ์กฐ๊ฑด๋ถ€ ํ•„์ˆ˜ ์˜์–‘์†Œ๋Š” ์‹ ์ฒด๊ฐ€ ๊ฑด๊ฐ•ํ•  ๋•Œ ์ถฉ๋ถ„ํ•œ ์–‘์ด ์ƒ์‚ฐ๋  ์ˆ˜ ์žˆ๋Š” ์˜์–‘์†Œ๋ฅผ ๋งํ•ฉ๋‹ˆ๋‹ค. ์‹ ์ฒด๊ฐ€ ํŠน์ • ์˜์–‘์†Œ๋ฅผ ํ•„์š”ํ•œ ๋งŒํผ ๋งŒ๋“ค์ง€ ๋ชปํ•˜๋Š” ๊ฒฝ์šฐ์—๋Š” ์‹๋‹จ์ด๋‚˜ ๋ณด์ถฉ์ œ๋ฅผ ํ†ตํ•ด ์„ญ์ทจ๋Ÿ‰์„ ์ถฉ๋ถ„ํ•œ ์ˆ˜์ค€์œผ๋กœ ๋Š˜๋ฆด ํ•„์š”๊ฐ€ ์žˆ์Šต๋‹ˆ๋‹ค. ๋‹ค๋ฅธ ์กฐ๊ฑด๋ถ€ ํ•„์ˆ˜ ์˜์–‘์†Œ๋กœ๋Š” ์ฝ”ํํ…์•ŒํŒŒ ๋ฆฌํฌ์‚ฐ์นด๋ฅด๋‹ˆํ‹ด(Carnitine)๊ธ€๋ฃจ์ฝ”์‚ฌ๋ฏผ(Glucosamine)์„ ๋“ค ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํšจ๋Šฅ

ํƒ€์šฐ๋ฆฐ์— ๊ด€ํ•œ ๋„์‹œ ์ „์„ค์ด ๋งŽ์Šต๋‹ˆ๋‹ค. ํƒ€์šฐ๋ฆฐ์ด ์—๋„ˆ์ง€ ์Œ๋ฃŒ์˜ ์„ฑ๋ถ„์œผ๋กœ ์ธ๊ธฐ๋ฅผ ๋Œ๋ฉด์„œ ์ด๋Ÿฌํ•œ ๊ทผ๊ฑฐ ์—†๋Š” ์†Œ๋ฌธ์ด ํ™•์‚ฐ๋˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ํƒ€์šฐ๋ฆฐ์ด ๊ฑด๊ฐ• ๋ฐ ์—๋„ˆ์ง€ ์ฆ์ง„์— ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค๋Š” ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋„ ๋งŽ์ด ๋‚˜์™€ ์žˆ์Šต๋‹ˆ๋‹ค. 

ํƒ€์šฐ๋ฆฐ์€ ์—๋„ˆ์ง€๋ฅผ ์ƒ์„ฑํ•˜๋Š” ์„ธํฌ์†Œ๊ธฐ๊ด€์ธ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ๊ฑด๊ฐ•์— ํ•„์ˆ˜์ ์ž…๋‹ˆ๋‹ค. ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ๊ธฐ๋Šฅ์ด ์ €ํ•˜๋˜๋ฉด ๋…ธํ™”๊ฐ€ ๊ฐ€์†ํ™”๋˜๊ณ  ์‹ ์ง„๋Œ€์‚ฌ ์žฅ์• ๊ฐ€ ์ƒ๊ธฐ๋ฉฐ ์‹ฌํ˜ˆ๊ด€ ๊ฑด๊ฐ•์ด ์•…ํ™”๋˜๊ณ  ์‹ ์ฒด์  ๋ฐ ์ •์‹ ์  ์—๋„ˆ์ง€๊ฐ€ ๊ฐ์†Œํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋‹ค์–‘ํ•œ ์‹คํ—˜ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ํƒ€์šฐ๋ฆฐ ๋ณด์ถฉ์ œ๋Š” ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ๊ธฐ๋Šฅ์— ๋„์›€์ด ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.2 ํ•œ ์ž„์ƒ์‹œํ—˜์—์„œ๋Š” ํƒ€์šฐ๋ฆฐ์ด ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ๊ธฐ๋Šฅ์ด ์†์ƒ๋œ ํ”ผํ—˜์ž์˜ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ๊ธฐ๋Šฅ์„ ํ˜„์ €ํžˆ ๊ฐœ์„ ํ•˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.3 ์ด๋Ÿฌํ•œ ๊ฒฐ๊ณผ๋Š” ํƒ€์šฐ๋ฆฐ์„ ๋ณด์ถฉํ–ˆ์„ ๋•Œ ๋‚˜ํƒ€๋‚˜๋Š” ์ผ๋ถ€ ํšจ๊ณผ๊ฐ€ ์—๋„ˆ์ง€ ์ƒ์‚ฐ์„ ์ง€์›ํ•˜๋Š” ํƒ€์šฐ๋ฆฐ์˜ ํŠน์„ฑ์— ๊ธฐ์ธํ•˜๋Š” ๊ฒƒ์ž„์„ ์‹œ์‚ฌํ•ฉ๋‹ˆ๋‹ค.2,3

์šด๋™ ๋Šฅ๋ ฅ ์ฆ์ง„

ํƒ€์šฐ๋ฆฐ์€ ๊ทผ์œก ์ˆ˜์ถ•์„ ๊ฐ•ํ™”ํ•˜๊ณ  ๊ทผ์œก์ด ํ”ผ๋กœํ•ด์ง€๋Š” ์‹œ์ ์„ ๋Šฆ์ถฐ ์‹ ์ฒด ๋Šฅ๋ ฅ์„ ๊ฐœ์„ ํ•˜๋Š” ๋ฐ ๋„์›€์ด ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.4 19๊ฑด์˜ ์ž„์ƒ ์—ฐ๊ตฌ์— ๋Œ€ํ•œ ์ƒ์„ธํ•œ ๋ฌธํ—Œ ๊ฒ€ํ† ์— ๋”ฐ๋ฅด๋ฉด ํƒ€์šฐ๋ฆฐ์€ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ํšจ๊ณผ๊ฐ€ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.

  • ์‚ฐ์†Œ์ด์šฉ๋ฅ ์„ ๋†’์ž…๋‹ˆ๋‹ค.
  • ํ”ผ๋กœ๋ฅผ ๋Š๋ผ๊ธฐ ์‹œ์ž‘ํ•˜๋Š” ์‹œ์ ์„ ๋Šฆ์ถฅ๋‹ˆ๋‹ค.
  • ์šด๋™์œผ๋กœ ์ธํ•œ ๊ทผ์œก ์†์ƒ์„ ์™„ํ™”ํ•ฉ๋‹ˆ๋‹ค.
  • ํšŒ๋ณต ์‹œ๊ฐ„์„ ์ค„์ž…๋‹ˆ๋‹ค.
  • ๊ทผ๋ ฅ ๋ฐ ํŒŒ์›Œ๋ฅผ ์ฆ๊ฐ€์‹œํ‚ต๋‹ˆ๋‹ค.

๋…ผ๋ฌธ ์ €์ž๋Š” ์ด๋Ÿฌํ•œ ํƒ€์šฐ๋ฆฐ์˜ ํšจ๋Šฅ์„ ์•ˆ์ „ํ•˜๊ณ  ํšจ๊ณผ์ ์œผ๋กœ ๋ˆ„๋ฆฌ๋ ค๋ฉด ์šด๋™ 1์‹œ๊ฐ„ ์ „์— 1-3g์„ ์„ญ์ทจํ•  ๊ฒƒ์„ ์ œ์‹œํ–ˆ์Šต๋‹ˆ๋‹ค. ์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ํƒ€์šฐ๋ฆฐ์˜ ํšจ๊ณผ๊ฐ€ ๋‚˜ํƒ€๋‚˜๊ธฐ๊นŒ์ง€๋Š” ๋Œ€์ฒด์ ์œผ๋กœ 1-3์ฃผ๊ฐ€ ๊ฑธ๋ฆด ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.4

์‹ฌ์žฅ ๊ฑด๊ฐ•

๋˜ํ•œ ํƒ€์šฐ๋ฆฐ์€ ์‹ฌ์žฅ ๊ทผ์œก์˜ ์ˆ˜์ถ•์„ ๊ฐ•ํ™”ํ•˜๋Š” ๋ฐ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•ฉ๋‹ˆ๋‹ค. ์ธ๊ตฌ ๊ธฐ๋ฐ˜ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ํƒ€์šฐ๋ฆฐ ์„ญ์ทจ๋Ÿ‰์€ ์‹ฌ์žฅ ๊ฑด๊ฐ•๊ณผ ๊ด€๋ จ์ด ์žˆ์Šต๋‹ˆ๋‹ค.5 ์—ฌ๋Ÿฌ ์ž„์ƒ ์—ฐ๊ตฌ์—์„œ๋Š” ํƒ€์šฐ๋ฆฐ์„ ๋ณด์ถฉํ•˜๋ฉด ์‹ฌ์žฅ ๋ฐ ํ˜ˆ๊ด€ ๊ธฐ๋Šฅ๊ณผ ๊ด€๋ จ๋œ ๋‹ค์–‘ํ•œ ์ด์ ์„ ์–ป์„ ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.6 ํƒ€์šฐ๋ฆฐ ๋ณด์ถฉ์ œ๋Š” ํŠนํžˆ ํ˜ˆ์•• ์กฐ์ ˆ, ์‹ฌ์žฅ ๊ธฐ๋Šฅ, ํ˜ˆ์ค‘ ์ฝœ๋ ˆ์Šคํ…Œ๋กค ์ˆ˜์น˜ ๊ฐœ์„ ์— ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค. ํ•œ ์ด์ค‘๋งน๊ฒ€ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด 2์ฃผ ๋™์•ˆ ๋งค์ผ 3ํšŒ 500mg์˜ ํƒ€์šฐ๋ฆฐ์„ ์„ญ์ทจํ•œ ํ”ผํ—˜์ž๋“ค์€ ์ด ์ฝœ๋ ˆ์Šคํ…Œ๋กค, ์ค‘์„ฑ์ง€๋ฐฉ, ์—ผ์ฆ ์ •๋„๋ฅผ ๋‚˜ํƒ€๋‚ด๋Š” ํ˜ˆ์•ก ์ง€ํ‘œ์ธ C-๋ฐ˜์‘์„ฑ ๋‹จ๋ฐฑ์งˆ(CRP)์ด ํ˜„์ €ํžˆ ๊ฐ์†Œํ–ˆ์Šต๋‹ˆ๋‹ค.7

๊ฐ„ ๋ฐ ๋‡Œ ๊ฑด๊ฐ•

ํƒ€์šฐ๋ฆฐ์€ ๊ฐ„ ๋ฐ ๋‡Œ ๊ฑด๊ฐ•์„ ๋•๋Š” ๊ฒƒ์œผ๋กœ ์ž˜ ์•Œ๋ ค์ ธ ์žˆ์Šต๋‹ˆ๋‹ค. ํƒ€์šฐ๋ฆฐ์€ ์‚ด์ถฉ์ œ, ์ œ์ดˆ์ œ, ๊ธฐํƒ€ ํ™˜๊ฒฝ ๋…์†Œ๋ฅผ ๋น„๋กฏํ•œ ๋‹ค์–‘ํ•œ ๋…์„ฑ๋ฌผ์งˆ๋กœ๋ถ€ํ„ฐ ๊ฐ„๊ณผ ๋‡Œ๋ฅผ ๋ณดํ˜ธํ•˜๋Š” ๋ฐ ํ•„์ˆ˜์ ์ธ ์˜์–‘์†Œ์ธ ๊ฒƒ์œผ๋กœ ์ž…์ฆ๋œ ๋ฐ” ์žˆ์Šต๋‹ˆ๋‹ค. ๊ฐ„์—์„œ ํƒ€์šฐ๋ฆฐ์€ ๊ฐ„ ์†์ƒ์„ ๋ฐฉ์ง€ํ•  ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ์œ ํ•ด๋ฌผ์งˆ์„ ํ•ด๋…ํ•ฉ๋‹ˆ๋‹ค. ๋‡Œ์—์„œ ํƒ€์šฐ๋ฆฐ์€ ๋…์†Œ์™€ ์‚ฐํ™” ์ŠคํŠธ๋ ˆ์Šค๋กœ๋ถ€ํ„ฐ ์„ธํฌ๋ฅผ ๋ณดํ˜ธํ•ฉ๋‹ˆ๋‹ค. ๋˜ํ•œ ํƒ€์šฐ๋ฆฐ์€ ํ˜ˆ์ค‘ ์•”๋ชจ๋‹ˆ์•„ ์ˆ˜์น˜ ์ƒ์Šน์„ ์–ต์ œํ•˜๊ณ  ์•”๋ชจ๋‹ˆ์•„์˜ ํ•ด๋กœ์šด ์˜ํ–ฅ์œผ๋กœ๋ถ€ํ„ฐ ๊ฐ„๊ณผ ๋‡Œ๋ฅผ ๋ณดํ˜ธํ•ฉ๋‹ˆ๋‹ค.2,8,9

์ธ์Š๋ฆฐ ๊ฐ์ˆ˜์„ฑ

ํƒ€์šฐ๋ฆฐ ๋ณด์ถฉ์ œ๋Š” ํ˜ธ๋ฅด๋ชฌ์ธ ์ธ์Š๋ฆฐ(Insulin)์— ๋Œ€ํ•œ ์ฒด๋‚ด ์กฐ์ง์˜ ๊ฐ์ˆ˜์„ฑ์„ ๋†’์ด๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ํšจ๊ณผ๋Š” ํ˜ˆ๋‹น ์–ต์ œ ๋ฐ ์‹์š• ์กฐ์ ˆ์— ๋„์›€์ด ๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ์ธ์Š๋ฆฐ ๊ฐ์ˆ˜์„ฑ๊ณผ ๊ด€๋ จ๋œ ํƒ€์šฐ๋ฆฐ์˜ ๋‹ค์–‘ํ•œ ํšจ๋Šฅ์€ ํƒ€์šฐ๋ฆฐ์˜ ํ•ญ์‚ฐํ™” ๋ฐ ํ•ญ์—ผ ํŠน์„ฑ ๋•ํƒ์— ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒƒ์œผ๋กœ ์ƒ๊ฐ๋ฉ๋‹ˆ๋‹ค.10,11 ํƒ€์šฐ๋ฆฐ์˜ ์ด๋Ÿฌํ•œ ํšจ๋Šฅ์„ ์„ค๋ช…ํ•˜๋Š” ๋˜ ๋‹ค๋ฅธ ๊ธฐ์ œ๊ฐ€ ์žˆ์„ ์ˆ˜๋„ ์žˆ์Šต๋‹ˆ๋‹ค. ํ•œ ์ด์ค‘ ๋งน๊ฒ€, ์œ„์•ฝ ๋Œ€์กฐ๊ตฐ ์—ฐ๊ตฌ์—์„œ๋Š” ๋น„๋งŒ ์—ฌ์„ฑ๊ณผ ๋น„๋งŒ์ด ์•„๋‹Œ ์—ฌ์„ฑ์—๊ฒŒ ๋งค์ผ 3g์˜ ํƒ€์šฐ๋ฆฐ์„ ํˆฌ์—ฌํ–ˆ์Šต๋‹ˆ๋‹ค. ๊ทธ ๊ฒฐ๊ณผ, ํƒ€์šฐ๋ฆฐ ์„ญ์ทจ ๊ทธ๋ฃน์˜ ์—ฌ์„ฑ์€ ์—ผ์ฆ ๋ฐ ์‚ฐํ™”์  ์†์ƒ์„ ๋‚˜ํƒ€๋‚ด๋Š” ํ˜ˆ์•ก ์ง€ํ‘œ๊ฐ€ ๊ฐ์†Œํ•œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ๋˜ํ•œ ํƒ€์šฐ๋ฆฐ์„ ๋ณด์ถฉํ•œ ๊ฒฝ์šฐ, ์ง€๋ฐฉ์„ธํฌ์—์„œ ๋ถ„๋น„๋˜๋Š” ํ˜ธ๋ฅด๋ชฌ์œผ๋กœ ์ธ์Š๋ฆฐ ๊ฐ์ˆ˜์„ฑ์„ ์ฆ์ง„ํ•˜๋Š” ์•„๋””ํฌ๋„ฅํ‹ด(Adiponectin) ์ˆ˜์น˜๋Š” ์ฆ๊ฐ€ํ–ˆ์Šต๋‹ˆ๋‹ค. ๋”ฐ๋ผ์„œ ํƒ€์šฐ๋ฆฐ์ด ์•„๋””ํฌ๋„ฅํ‹ด ์ˆ˜์น˜๋ฅผ ๋†’์ด๋Š” ๊ฒƒ๋„ ์ธ์Š๋ฆฐ ์ž‘์šฉ์„ ๊ฐœ์„ ํ•˜๋Š” ๋˜ ๋‹ค๋ฅธ ๊ธฐ์ œ์ผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.12

๋‹ค์–‘ํ•œ ๋™๋ฌผ ๋ชจ๋ธ์„ ์‚ฌ์šฉํ•œ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ํƒ€์šฐ๋ฆฐ์€ ์—ฌ๋Ÿฌ ๊ธฐ์ œ๋ฅผ ํ†ตํ•ด ์ ์ ˆํ•œ ์ฒด์ค‘์„ ์œ ์ง€ํ•˜๋Š” ๋ฐ ๋„์›€์ด ๋˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ์˜ˆ๋ฅผ ๋“ค์–ด, ํ•œ ์—ฐ๊ตฌ์—์„œ 2% ํƒ€์šฐ๋ฆฐ์ด ํฌํ•จ๋œ ๊ณ ์ง€๋ฐฉ์‹์„ ์„ญ์ทจํ•œ ์ฅ๋Š” ํƒ€์šฐ๋ฆฐ์ด ์—†๋Š” ๊ณ ์ง€๋ฐฉ์‹๋งŒ ์„ญ์ทจํ•œ ๊ฒฝ์šฐ์— ๋น„ํ•ด ์ฒด์ค‘์ด ํฌ๊ฒŒ ๊ฐ์†Œํ•œ ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค. ์ด์ฒ˜๋Ÿผ ์ฒด์งˆ๋Ÿ‰์ด ๊ฐ์†Œํ•œ ์ด์œ ๋Š” ์ง€๋ฐฉ ์ถ•์ ์„ ์œ ๋ฐœํ•˜๋Š” ์ง€๋ฐฉ์„ธํฌ์˜ ์œ ์ „์ž ๋ฐœํ˜„์ด ๊ฐ์†Œํ–ˆ๊ธฐ ๋•Œ๋ฌธ์ผ ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์Šต๋‹ˆ๋‹ค. ๊ณ ๋ฌด์ ์ธ ๊ฒฐ๊ณผ์ด๊ธฐ๋Š” ํ•˜์ง€๋งŒ, ์ธ๊ฐ„์„ ๋Œ€์ƒ์œผ๋กœ ํ•œ ์—ฐ๊ตฌ์—์„œ๋Š” ์ง€๊ธˆ๊นŒ์ง€ ์ฒด์ค‘ ๊ฐ๋Ÿ‰์„ ์ด‰์ง„ํ•˜๋Š” ํƒ€์šฐ๋ฆฐ ๋ณด์ถฉ์ œ์˜ ํšจ๊ณผ๊ฐ€ ์ž…์ฆ๋œ ์ ์ด ์—†๋‹ค๋Š” ์‚ฌ์‹ค์— ์œ ์˜ํ•ด์•ผ ํ•ฉ๋‹ˆ๋‹ค.13

๋ง๋ง‰ ๊ฑด๊ฐ•

ํƒ€์šฐ๋ฆฐ์€ ๋‡Œ์„ธํฌ ๋ฐ ์‹ ๊ฒฝ์„ธํฌ๊ฐ€ ์ •์ƒ์ ์œผ๋กœ ๋ฐœ๋‹ฌํ•˜๋Š” ๋ฐ ํ•„์š”ํ•œ ์ค‘์š”ํ•œ ์•„๋ฏธ๋…ธ์‚ฐ์ž…๋‹ˆ๋‹ค. ํƒ€์šฐ๋ฆฐ์€ ์‹œ๋ ฅ์„ ๋‹ด๋‹นํ•˜๋Š” ์‹ ๊ฒฝ ์กฐ์ง์ธ ๋ง๋ง‰์˜ ๋ฐœ๋‹ฌ์—๋„ ๊ด€์—ฌํ•ฉ๋‹ˆ๋‹ค. ์‹ค์ œ๋กœ ์ธ์ฒด์—์„œ ํƒ€์šฐ๋ฆฐ์ด ๊ฐ€์žฅ ํ’๋ถ€ํ•œ ๊ณณ์€ ๋ง๋ง‰์ž…๋‹ˆ๋‹ค. ๋ง๋ง‰์— ์กด์žฌํ•˜๋Š” ๋Œ€๋ถ€๋ถ„์˜ ํƒ€์šฐ๋ฆฐ์€ ๊ด‘์ˆ˜์šฉ์ฒด๊ฐ€ ๋น›์„ ์‹ ๊ฒฝ ์ž๊ทน์œผ๋กœ ๋ณ€ํ™˜ํ•˜๋Š” ๋ง๋ง‰ ์™ธ๋ถ€ ์˜์—ญ์— ๋ถ„ํฌํ•ฉ๋‹ˆ๋‹ค. ํƒ€์šฐ๋ฆฐ์€ ๋ง๋ง‰์˜ ๋ฐœ๋‹ฌ, ๊ธฐ๋Šฅ๋ฟ ์•„๋‹ˆ๋ผ ํ•ญ์‚ฐํ™” ์ž‘์šฉ์—๋„ ํ•„์ˆ˜์ ์ธ ๊ฒƒ์œผ๋กœ ์ƒ๊ฐ๋ฉ๋‹ˆ๋‹ค. ๋ง๋ง‰์˜ ํƒ€์šฐ๋ฆฐ ์ˆ˜์น˜๊ฐ€ ๊ฐ์†Œํ•˜๋ฉด ๋ง๋ง‰๋ณ€์„ฑ ๋˜๋Š” ํ™ฉ๋ฐ˜๋ณ€์„ฑ์ด ์ƒ๊ธธ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.14  

ํฌ์œ ๋™๋ฌผ์˜ ๋ง๋ง‰์ด ์ •์ƒ์ ์œผ๋กœ ๊ธฐ๋Šฅํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” ํƒ€์šฐ๋ฆฐ์„ ์„ญ์ทจํ•ด์•ผ ํ•œ๋‹ค๋Š” ์‚ฌ์‹ค์ด ์—ฐ๊ตฌ์—์„œ ์ž…์ฆ๋œ ๋ฐ” ์žˆ์Šต๋‹ˆ๋‹ค. ์ด๋Ÿฌํ•œ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋Š” ์‹ ์ฒด์—์„œ ์ƒ์„ฑ๋˜๋Š” ํƒ€์šฐ๋ฆฐ๋งŒ์œผ๋กœ ๋ง๋ง‰์˜ ํƒ€์šฐ๋ฆฐ ์š”๊ตฌ๋Ÿ‰์„ ์ถฉ์กฑํ•  ์ˆ˜ ์žˆ๋‹ค๊ณ  ์ƒ๊ฐํ•˜๋Š” ๊ฒƒ์ด ํ˜„๋ช…ํ•œ ํŒ๋‹จ์ด ์•„๋‹˜์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค. ํƒ€์šฐ๋ฆฐ์ด ์—†๋Š” ์‚ฌ๋ฃŒ๋ฅผ ์„ญ์ทจํ•˜๊ฑฐ๋‚˜ ํƒ€์šฐ๋ฆฐ์˜ ์ฒด๋‚ด ์ด์šฉ์„ ์ฐจ๋‹จํ•˜๋Š” ์•ฝ๋ฌผ์„ ๋ณต์šฉํ•œ ๋™๋ฌผ์€ ๋ง๋ง‰๋ณ€์„ฑ๊ณผ ์‹œ๋ ฅ ์†์ƒ์ด ์ƒ๊ธฐ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค. ์ž„์ƒ์‹œํ—˜ ๊ฒฐ๊ณผ๋„ ์ด๋ฅผ ๋’ท๋ฐ›์นจํ•ฉ๋‹ˆ๋‹ค. ์ •๋งฅ ์˜์–‘์ œ๊ฐ€ ์ฒ˜์Œ ์‚ฌ์šฉ๋œ ์ดํ›„๋กœ ๋งŽ์€ ์‹œ๊ฐ„์ด ์ง€๋‚˜ 1980๋…„๋Œ€ ์ค‘๋ฐ˜์— ์ด๋ฅด๋Ÿฌ์„œ์•ผ ์ •๋งฅ ์˜์–‘์ œ์— ํƒ€์šฐ๋ฆฐ์ด ํฌํ•จ๋˜๊ธฐ ์‹œ์ž‘ํ–ˆ์Šต๋‹ˆ๋‹ค. ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ์žฅ๊ธฐ๊ฐ„์— ๊ฑธ์ณ ์ •๋งฅ์˜์–‘๋ฒ•์œผ๋กœ ๋Œ€๋ถ€๋ถ„์˜ ์˜์–‘์„ ๊ณต๊ธ‰๋ฐ›์•„์•ผ ํ–ˆ๋˜ ์–ด๋ฆฐ์ด๋Š” ํƒ€์šฐ๋ฆฐ ์ˆ˜์น˜๊ฐ€ ๋‚ฎ์•„์ ธ ์‹œ๊ฐ ๋ฐ˜์‘์ด ์†์ƒ๋œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.15 

ํƒ€์šฐ๋ฆฐ์€ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ๊ธฐ๋Šฅ ๋ฐ ํ•ญ์‚ฐํ™” ์ž‘์šฉ์„ ์ง€์›ํ•˜๊ณ  ๋ง๋ง‰์˜ ๊ด‘์ˆ˜์šฉ์ฒด๋ฅผ ๋ณดํ˜ธํ•˜๋Š” ๋ฐ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜๋ฏ€๋กœ ๋ง๋ง‰ ๊ฑด๊ฐ•์„ ์ฆ์ง„ํ•˜๋ ค๋ฉด ํƒ€์šฐ๋ฆฐ ๋ณด์ถฉ์ œ๋ฅผ ์„ญ์ทจํ•˜๋Š” ๊ฒƒ์ด ์ข‹์Šต๋‹ˆ๋‹ค. ๋ง๋ง‰ ๊ธฐ๋Šฅ์ด ์ €ํ•˜๋œ ๋™๋ฌผ ๋ชจ๋ธ์— ํƒ€์šฐ๋ฆฐ์„ ํˆฌ์—ฌํ•˜๋ฉด ๊ฐœ์„  ํšจ๊ณผ๊ฐ€ ๋‚˜ํƒ€๋‚ฌ๋‹ค๋Š” ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋„ ์žˆ์Šต๋‹ˆ๋‹ค. ์—ฌ๋Ÿฌ ์ž„์ƒ ์—ฐ๊ตฌ์—์„œ๋Š” ํƒ€์šฐ๋ฆฐ ์ˆ˜์น˜๊ฐ€ ๋‚ฎ์œผ๋ฉด ๋ง๋ง‰ ๊ฑด๊ฐ•์ด ๋‚˜๋น ์ง€์ง€๋งŒ ํƒ€์šฐ๋ฆฐ ์ˆ˜์น˜๊ฐ€ ๋†’์œผ๋ฉด ๋ง๋ง‰ ๊ฑด๊ฐ•์ด ํ–ฅ์ƒ๋  ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค.16 

๊ฒฐ๋ก 

ํƒ€์šฐ๋ฆฐ์€ ์ง€๋ฐฉ ํก์ˆ˜๋ฅผ ๋•๊ณ  ์„ธํฌ์˜ ์ˆ˜๋ถ„ ํ•จ๋Ÿ‰์„ ์œ ์ง€ํ•˜๋ฉฐ ์‹ ๊ฒฝ ๊ธฐ๋Šฅ์„ ์ง€์›ํ•˜๋Š” ๊ฒƒ๊ณผ ๊ฐ™์€ ๊ณ ์œ ํ•œ ๊ธฐ๋Šฅ์„ ์ˆ˜ํ–‰ํ•˜๋Š” ์ค‘์š”ํ•œ ์•„๋ฏธ๋…ธ์‚ฐ์ž…๋‹ˆ๋‹ค. ํƒ€์šฐ๋ฆฐ์€ ์œก๋ฅ˜, ํ•ด์‚ฐ๋ฌผ, ์œ ์ œํ’ˆ์— ํ•จ์œ ๋˜์–ด ์žˆ์œผ๋ฉฐ ์‹๋ฌผ์„ฑ ์‹ํ’ˆ์—๋Š” ์ ๊ฒŒ ๋“ค์–ด ์žˆ์Šต๋‹ˆ๋‹ค. ์ธ์ฒด๋Š” ํƒ€์šฐ๋ฆฐ์„ ์ƒ์„ฑํ•  ์ˆ˜ ์žˆ์ง€๋งŒ ํŠน์ • ์กฐ๊ฑด์—์„œ๋Š” ๋ณด์ถฉ์ด ํ•„์š”ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. 

์ฐธ๊ณ ๋ฌธํ—Œ:

  1. Wu G. Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health. Amino Acids. 2020 Mar;52(3):329-360. 
  2. Jong CJ, Sandal P, Schaffer SW. The Role of Taurine in Mitochondria Health: More Than Just an Antioxidant. Molecules. 2021 Aug 13;26(16):4913.
  3. Ohsawa Y, Hagiwara H, Nishimatsu SI, et al. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2019 May;90(5):529-536. 
  4. Kurtz JA, VanDusseldorp TA, Doyle JA, Otis JS. Taurine in sports and exercise. J Int Soc Sports Nutr. 2021 May 26;18(1):39. 
  5. Murakami S. Taurine and atherosclerosis. Amino Acids. 2014 Jan;46(1):73-80
  6. Qaradakhi T, Gadanec LK, McSweeney KR, et al. The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease. Nutrients. 2020 Sep 17;12(9):2847.
  7. Ahmadian M, Roshan VD, Aslani E, Stannard SR. Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure. Ther Adv Cardiovasc Dis. 2017 Jul;11(7):185-194. 
  8. Jakaria M, Azam S, Haque ME, et al. Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biol. 2019 Jun;24:101223.
  9. Heidari R, Jamshidzadeh A, Niknahad H, et al. Effect of taurine on chronic and acute liver injury: Focus on blood and brain ammonia. Toxicol Rep. 2016 Apr 13;3:870-879. 
  10. Sirdah MM. Protective and therapeutic effectiveness of taurine in diabetes mellitus: a rationale for antioxidant supplementation. Diabetes Metab Syndr. 2015 Jan-Mar;9(1):55-64. 
  11. Ahmed K, Choi HN, Yim JE. The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect. Endocrinol Metab (Seoul). 2023 Oct;38(5):482-492. .
  12. Rosa FT, Feitas EC, Deminice R, Jordฤƒo AA, Marchini JS. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr. 2014;53(3):823-830.
  13. Ahmed K, Choi HN, Yim JE. The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect. Endocrinol Metab (Seoul). 2023 Oct;38(5):482-492.
  14. Garcรญa-Ayuso D, Di Pierdomenico J, Martรญnez-Vacas A, Vidal-Sanz M, Picaud S, Villegas-Pรฉrez MP. Taurine: a promising nutraceutic in the prevention of retinal degeneration. Neural Regen Res. 2024 Mar;19(3):606-610.
  15. Ament ME, Geggel HS, Heckenlively JR, Martin DA, Kopple J. Taurine supplementation in infants receiving long-term total parenteral nutrition. J Am Coll Nutr. 1986;5:127โ€“135.
  16. Gรผngel H, Erdenen F, Pasaoglu I, Sak D, Ogreden T, Kilic Muftuoglu I. New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels. Curr Eye Res. 2021 Jun;46(6):818-823.